Allianz Asset Management GmbH - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 202 filers reported holding MYRIAD GENETICS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$402,604
-95.0%
25,100
-92.8%
0.00%
-92.9%
Q1 2023$8,130,825
+68.8%
350,014
+5.4%
0.01%
+55.6%
Q4 2022$4,817,770
-17.2%
332,031
+8.9%
0.01%
-25.0%
Q3 2022$5,818,000
+58.3%
304,931
+50.8%
0.01%
+300.0%
Q2 2022$3,675,000
-7.8%
202,254
+27.9%
0.00%0.0%
Q1 2022$3,985,000
+16.9%
158,143
+28.0%
0.00%
+50.0%
Q4 2021$3,410,000
-19.7%
123,552
-6.0%
0.00%
-33.3%
Q3 2021$4,245,000
+601.7%
131,452
+491.0%
0.00%
+200.0%
Q4 2019$605,000
-5.5%
22,243
-0.5%
0.00%0.0%
Q3 2019$640,000
-59.4%
22,356
-60.6%
0.00%0.0%
Q2 2019$1,575,000
-43.8%
56,733
-32.7%
0.00%
-66.7%
Q1 2019$2,801,000
+120.2%
84,360
+92.7%
0.00%
+200.0%
Q4 2018$1,272,000
-80.9%
43,776
-69.8%
0.00%
-83.3%
Q3 2018$6,661,000
-68.9%
144,823
-74.7%
0.01%
-71.4%
Q2 2018$21,405,000
+18.7%
572,771
-6.1%
0.02%
+23.5%
Q1 2018$18,031,000
+8.2%
610,190
+25.8%
0.02%
+30.8%
Q4 2017$16,658,000
+3982.8%
485,018
+4202.5%
0.01%
Q3 2017$408,000
+50.0%
11,273
+6.3%
0.00%
Q2 2017$272,000
+40.2%
10,608
+5.1%
0.00%
Q1 2017$194,000
+3.7%
10,093
-10.3%
0.00%
Q4 2016$187,000
-19.7%
11,2470.0%0.00%
Q3 2016$233,000
-51.7%
11,247
-28.7%
0.00%
-100.0%
Q2 2016$482,000
-18.3%
15,7670.0%0.00%0.0%
Q1 2016$590,000
+21.6%
15,767
+40.2%
0.00%0.0%
Q4 2015$485,000
+14.9%
11,2470.0%0.00%0.0%
Q3 2015$422,000
-36.9%
11,247
-42.9%
0.00%0.0%
Q2 2015$669,000
-19.6%
19,692
-16.2%
0.00%0.0%
Q1 2015$832,000
+4.0%
23,4900.0%0.00%0.0%
Q4 2014$800,000
-22.9%
23,490
-12.6%
0.00%0.0%
Q3 2014$1,037,000
-1.0%
26,8900.0%0.00%0.0%
Q2 2014$1,047,000
+11.5%
26,890
-2.1%
0.00%0.0%
Q1 2014$939,000
-30.5%
27,469
-57.4%
0.00%
-50.0%
Q4 2013$1,352,000
+11.3%
64,462
+24.7%
0.00%0.0%
Q3 2013$1,215,000
-78.5%
51,686
-75.4%
0.00%
-75.0%
Q2 2013$5,644,000210,0730.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders